Τόμος 19 (2001) – Τεύχος 2 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 19 (2001) – Issue 2 – Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

 

Τίτλος – Title

Ακμή: Κλινικές Μορφές και Αντιμετώπιση

Acne: Clinical Diagnosis and Therapeutic Management

Συγγραφέας – Author

Βασιλική Κεφαλά

Σχολή Επαγγελμάτων Υγείας και Πρόνοιας, Τεχνολογικό Εκπαιδευτικό Ίδρυμα (ΤΕΙ) Αθήνας, Αθήνα, Ελλάς

Vassiliki Kefala

Technological Educational Institution, Athens Greece

Παραπομπή – Citation

Κεφαλά,Β. : Ακμή: Κλινικές Μορφές και Αντιμετώπιση, Επιθεώρηση Κλιν. Φαρμακολ. Φαρμακοκινητ. 19 : 63-76 (2001)

Kefala,V. : Acne: Clinical Diagnosis and Therapeutic Management, Epitheorese Klin. Farmakol. Farmakokinet. 19: 63-76 (2001)

Ημερομηνία Δημοσιευσης – Publication Date
25-02-2001 – 2001-02-25
Γλώσσα Πλήρους Κειμένου –
Full Text Language

Ελληνικά – Greek

Παραγγελία – Αγορά –
Order – Buy
Ηλεκτρονική Μορφή: pdf (15 €)
Digital Type: pdf (15 )
pharmakonpress[at]pharmakonpress[.]gr
Λέξεις κλειδιά – Keywords

Ακμή, κοινή, φαγεσωρική, επιφανειακή, κυστική, κεραυνοβόλος, επαγγελματική, τροπική, από καλλυντικά, προκλητή, ροδόχροη, Gram(-) θυλακίτιδα, τετρακυκλίνες, μινοκυκλίνη, βενζοϋλο-υπεροξείδιο, ρετινοειδή, οξεική κυπροτερόνη, ισοτρετινοΐνη, αντιανδρογόνα

Acne, vulgaris, comedo, superficial, cystic, gram(-) folliculitis, fulminans, oc­cupational, tropical, iatrogenic, cosmetic, excoriated, rosacea, tetracyclines, mino­cycline, benzoyl peroxide, retinoids, cyptoterone acecate, isotretinoin, antiandrogens
Λοιποί Όροι – Other Terms

Άρθρο

Article

Περίληψη – Summary

Έννοια σχεδόν ταυτόσημη με την εφηβεία, η κοινή ακμή, νόσος του τριχοσμηγματογόνου συστήματος χαρακτηρίζεται κλινικώς από πολύμορφο εξάνθημα αποτελούμενο από φαγέσωρους, φλύκταινες, οζίδια, βλατίδες, κύστεις και ουλές, με εντόπιση σε περιοχές πλούσιες σε σμηγματογόνους αδένες όπως είναι το πρόσωπο, οι ώμοι και η πλάτη. Η αιτιολογία της ακμής είναι πολυπαραγοντική, η διαδρομή της μακρά, οι υποτροπές της συχνές, αλλά παρά ταύτα αντιμετωπίζεται σήμερα με επιτυχία σε υψηλό ποσοστό. Επιχειρείται εδώ η ταξινόμηση της σε διάφορους τύπους, η διαβάθμιση των ποικίλων μορφών της, ανάλογα με την ποσότητα και την ποιότητα των δερματικών βλαβών. Κι αυτό, παρά το γεγονός ότι οι τύποι της ακμής προσομοιάζουν, εθεωρήθη αναγκαίο, γιατί έστω και η ατελής αναγνώριση των κλινικοπαθολογικών μορφών της είναι απαραίτητη προϋπόθεση θεραπείας. Επιχειρείται ακόμη να δοθούν απαντήσεις σε φαινομενικά απλά ερωτήματα που απασχολούν τους πάσχοντες και τα οποία σχετίζονται με την επιστημονική διάσταση της νόσου, καθώς και ολόκληρο το φάσμα της θεραπευτικής απόδοσης και της αξίας των φαρμάκων που χρησιμοποιούνται για την αντιμετώπισή της.

A condition quite synonymous with puberty, the common acne, disease of the piloseba­ceous glands, is clinically characterized by a poly­morphous exanthema consisting of comedones, pustules, papules, nodules, cysts and scars situated in areas rich in sebaceous gland, such as the face, the shoulders and the back. The etiology of the dis­ease is multi-factorial, its course is long and its re­lapses are frequent. However, it is currently treated with success in most of the cases. We are hereby trying to classify acne into different types, to stratify its variable forms according to the quantity and the quality of the skin lesions. Despite the similarity among the different forms of acne, this has been considered as a necessity, because even the in­complete recognition of the clinical forms of acne is a prerequisite to treatment. We are also trying to give answers to apparently simple questions occu­pying the suffers and relating to the scientific dimen­sion of the disease as well as to the whole spectrum of the therapeutic efficacy and of the value of the medicines used in the treatment of acne.

Αναφορές – References
1. Landow K.: Dispelling myths about acne. Postgrad. Med. 102: 94-99, 103-104, 110-112 (1997)

2. Amblard P.: Acne. Physiopathology, clinical aspects, treatment. Rev. Prcat. 40: 662-664 (1990)

3. Thiboutot D.M.: Acne. An overview of clinical research findings. Dermatol. Clin. 15: 97-109 (1997)

4. Jurecka W., Fanta D.: Autoradiographic investigations in actinic (Senile) comedones. Arch. Dermatol. Res. 260: 81-86 (1977)

5. Gallen B.A.: Acne vulgaris. Lippincotts Prim. Care Pract. 1: 88-92 (1997)

6. Rothman K.F., Lucky A.W.: Acne vulgaris. Adv. Dermatol. 8: 347-374 (1993)

7. Webster G.F.: Inflammation in acne vulgaris. J. Am. Acad. Dermatol. 33: 247-253 (1995)

8. Kefala V., Plessas S.T.: Topical and Systemic Therapeutic Management of Acne. Epitheor. Klin. Farmakol. Farmakokinet. Int. Ed. 14: 101-110 (2000)

9. Winston M.H., Shalita A.R.: Acne vulgaris Pathogenesis and treatment. Pediatr. Clin. North. Am. 38: 889-903 (1991)

10. Faure M.: Acne. Etiology, physiopathology, diagnosis, treatment. Rev. Prat. 46: 887-892 (1996)

11. Faure M. : Acne. Etiology, physiopathology, diagnosis, treatment. Rev. Prat. 43: 1301-1305 (1993)

12. Leyden J.J.: New understandings of pathogenesis of acne. J. Am. Acad. Dermatol. 32: 15-25 (1995)

13. Harris H.H. et al.: Essential fatty acids and acne. J. Am. Acad. Dermatol. 14: 221-224 (1986)

14. Marples R.R.: The microflora of the face and acne lesions. J. Invest. Dermatol. 62: 326-327 (1974)

15. Puhvel S.M. et al.: Quantification of bacteria in isolated pilosebaseous follicles in normal skin. J. Invest. Dermatol. 65: 525-529 (1975)

16. Kligman A.M.: Acne vulgaris: tricks and treatments. Part I. Cutis 56 (3) : 141-143 (1995)

17. Shalita A. et al.: A comparison of the efficacy and safety of adapalane gel 0,1% and tretinoin gel 0.0025% in the treatment of acne vulgaris: A multicenter trial. J. Am.

18. Shalita A. et al.: Double – blind study of AGN 190168, a new retinoid gel, in the topical treatment of acne vulgaris. J. Invest. Dermatol. 100: 542-550 (1993)

19. Black P.A.: Acne vulgaris. Prof. Nurse. 11: 181-183 (1995)

20. Seukeran D.C., Eady A.E., Cunliffe W.J.: Benefit risk assessment of acne therapies. Lancet 349: 1251-1253 (1997)

21. Tucker S.B. et al.: Inflammation in acne. Leukocyte attraction and cytotoxity by comedonal material. J. Invest. Dermatol. 74: 21-28 (1980)

22. Le Bozec P.: Follicular staphylococcal infections. Rev. Prat. 46: 1599-1602 (1996)

23. Shalita A., Weiss J.S., Chalker D.K., Elis C.N., Greenspa A., Katz H.J., Kantor I., Millikan L.E., Swinhart T., Swinyer L., Whitmore C., Baker M., Czernielewski J.: A comparison of the efficacy and safety of adapalene gel 0,1% and tretinoin gel 0,025% in the treatment of acne vulgaris: a multicenter trial. J. Am. Acad. Dermatol. 34: 482-485 (1996)

24. Fanta D., Bardach H., Poitscheck C.: Investigations on the bacteriostatic effect of benzoyl peroxide. Arch. Dermatol. Rec. 264: 369-371 (1979)

25. Fanta D.: Clinical and experimental studies on the effect of benzoyl peroxide in the treatment of acne. Hautarzt 29: 481-486 (1978)

26. Bergfeld W.F.: The evaluation and management of acne: economic considerations. J. Am. Acad. Dermatol. 32: 52-56 (1995)

27. Lucky A.W. et al.: Acne vulgaris in premenarchal girls. Arch. Dermatol. 130: 308-315 (1994)

28. Lucky A.W.: A review of infantile and pediatric acne. Dermatology 196 (1): 95-97 (1998)

29. Jansen T., Burgdorf W.H., Plewing G.: Pathogenesis and treatment of acne in childhood. Pediatr. Dermatol. 14: 17-21 (1997)

30. Janniger C.K.: Neonatal and infantile acne vulgaris. Cutis 52: 16 (1993)

31. Strasburger V.C.: Acne. What every pediatrician should know about treatment. Pediatr. Clin. North. Am. 44 (6): 1505-1523 (1997)

32. Gollnick H.: A new therapentic agent: Azelaic acid in acne treatment. J. Dermatol. Treat. 1: 523-527 (1990)

33. Schram M., Gollnick H.: Continous education for acne basics, pathogenesis, differential diagnosis, clinic and therapy- Development of an interactive hypermedia application on CD-ROM for computer based learning and instruction. Dermatology 196 (1): 100-101 (1998)

34. Brown S.K., Shalita A.R.: Acne vulgaris. Lancet. 351: 1871-1876 (1998)

35. Fanta D., Jerecka W.: Autoradiographic investigation on benzoyl peroxide treated skin. Acta. Derm. Venereol. 58: 361-363 (1978)

36. Fanta D., Formanek I., Poitschek C., Thurner J.: Porphyrinsynthesis of Propionibacterium acne in acne and seborrhea. Arch. Dermatol. Res. 261: 175-179 (1978)

37. Rossen M.H., Roed Petersen J.: Acne vulgaris. Ugerskr. Laeger. 155: 775-778 (1993)

38. Kligman A.M.: Postmenopausal acne. Cutis 47: 425-426 (1991)

39. Puhvel S. M. et al.: Lymphocyte transformation in subjects with nodulocystic acne vulgaris. Br. J. Dermatol. 97: 205-208 (1977)

40. Jansen T., Plewing G.: Advances and perspectives in acne therapy. Eur. J. Med. Res. 2: 321-334 (1997)

41. Toyoda M., Motohashi M.: An overview of topical antibiotics for acne treatment. Dermatology 196 (1): 130-134 (1998)

42. Goulden V., Glass D., Cunliffe W.J.: Safety of long term high dose minocycline in the treatment of acne. Brit J. Dermatol. 134: 693-695 (1996)

43. Shenefelt P.D.: Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen. Cutis 57: 315-319 (1996)

44. Marynick S.P. et al.: Androgen excess in cystic acne. N. Engl. J. Med. 308: 981-988 (1983)

45. Peck G.L. et al.: Isotretinoin versus placebo in the treatment of cystic acne. J. Am. Acad. Dermatol. 6: 735-737 (1982)

46. Stern R.S. et al.: Isotretinoin and pregnancy. J. Am. Acad. Dermatol. 10: 851-857 (1984)

47. Strauss J.S., Stranieri A.M.: Changes in long-term sebum production from isotretinoin therapy. J. Am. Acad. Dermatol. 6: 751-755 (1982)

48. Leyden J.J. et al.: Prolonged reduction of Propionibacterium acnes in acne conglobata patients treated with 13-cis retinoic acid. J. Invest. Dermatol. 78: 350-356 (1982)

49. Von den Driesch P.: Pyoderma gangrenosum: a report of 44 cases with follow – up. Br. J. Dermatol. 137: 1000-1005 (1997)

50. Powerll F.C., Su W.P.D., Perry H.O.: Pyoderma Gangrenosum: Classification and Management. J. Am. Acad. Dermatol. 34: 395-409 (1996)

51. Jansen T., Plewig G.: An historical note on pyoderma faciale. Br. J. Dermatol. 129: 594-599 (1993)

52. Plewing G. et al.: Pyoderma faciale: A review and report of 20 additional cases: Is it rosacea? Arch. Dermatol. 128: 1611-1620 (1992)

53. Fanta D., Niebauer G.: Progress in medicine in individual presentations, XI. Modern forms of therapy in acne. Wien. Klin. Wochenschr 89: 677-683 (1977)

54. Stathakis V., Kilkenny M., Marks R.: Descriptive epidemiology of acne vulgaris in the community. Australas J. Dermatol. 38: 115-123 (1997)

55. Matsuoka L.Y.: Acne and related disorders. Clin. Plast. Surg. 20: 35-41 (1993)

56. Webster G.F.: Inflammatory acne. Int. J. Dermatol. 29: 317-319 (1990)

57. Goldstein B., Chalker D.W., Lesher J.L.: Acne fulminans. South Med. J. 83 (6): 705-708 (1990)

58. Goldshmidt H. et al.: Acne fulminans: Investigation of acute febrile ulcerative acne. Arch. Dermatol. 113: 444-451 (1977)

59. Choudhry R. et al.: Localization of androgen receptors in human skin by immunohistorchemistry: Implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J. Endocrinol. 133: 467-473 (1991)

60. Cunliffe W., Forster R.: Androgen control of the pilosebaceous duct? Br. J. Dermatol. 116: 449-453 (1987)

61. Randall V. et al.: Androgens and the hair follicle. Ann. N.Y. Acad. Sci. 642: 355-364 (1991)

62. Thiboutot D. et al.: Activity of type 1 Sareductase is greater in the follicular infrainfundibulum compared with the epidermis. Br. J. Dermatol. 136: 166-172 (1997)

63. Bunker C.: Most women with acne have polycystic ovaries. Br. J. Dermatol. 121: 675-685 (1989)

64. Betti R.: Indidence of polycystic ovaries in patients with late-onset acne: Hormonal reports. Dermatological 181: 101-121 (1990)

65. Redmond G. et al.: Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo – controlled trial. Obstet. Gynecol. 89: 615-619 (1997)

66. Marcoux D., Thiboutot D.: Hormonal therapy for acne. J. Cutan. Med. Surg. 1: 1-7 (1996)

67. Hjorth N. et al.: Acne aestivalis – Mallorca acne. Acta. Derm. Venereol. 52: 61-64 (1972)

68. Mills O.H., Kligman A.M.: Acne astivalis. Arch. Dermatol. 111: 891-895 (1975)

69. Gought A.: Minocycline – induced autoimmune hepatitis and systemic lupus erythematosus – like syndrome. Br. Med. J. 312: 169-176 (1996)

70. Speroff L., De Cherney A.: Evaluation of a new generation of oral contraceptives. Obstet. Gynecol. 81: 1034-1036 (1993)

71. Kligman A.M., Mills O.H.: Acne cosmetica. Arch. Dermatol. 106: 843-891 (1972)

72. Plewing G. et al.: Pomade acne. Arch. Dermatol. 101: 580-583 (1970)

73. Mills O.H., Kligman A.M.: Acne detergicans. Arch. Dermatol. 111: 65-76 (1975)

74. Kischer C.W., Shetiar M.R., Shetlar C.L.: Alteration of hypertrophic scars induced my mechanical pressure. Arch. Dermatol. 111: 60-64 (1975)

75. Koo J.: The psychosocial impact of acne: Patients’ perceptions. J. Am. Acad. Dermatol. 32: 526-530 (1995)

76. Krowchuk D.P.: The psychosocial effects of acne on adolescents. Pediatr. Dermatol. 8: 332-339 (1991)

77. Mills O.H., Kligman A.M.: Acne mechanica. Arch. Dermatol 111: 481-487 (1975)

78. Webster G.F.: Acne and rosacea. Med. Clin. North. Am. 82 (5): 1145-1154 (1998)

79. Aizawa H. Niimuta M.: Oral spironolactone therapy in male patients with rosacea. J. Dermatol. 19: 293-297 (1992)

80. Carmichael A.J. et al.: Topical azelaic acid in the treatment of rosacea. J. Dermatol. Treat. 4: 19-25 (1993)

81. Kligman A.M.: Topical tretinoin for rosacea: A preliminary report. J. Dermatol. Treat. 4: 71-78 (1993)

82. Jansen T. et al.: Diagnosis and treatment of rosacea fulminans. Dermatology 188: 251-256 (1994)

83. De Bersaques J.: Historical notes an acne rosacea. Eur. J. Dermatol. 5: 16-27 (1995)

84. Millikan L.E., Shrum J.P.: An update on common skin diseases. Acne, psoriasis, contact dermatitis and warts. Postgrad. Med. 91: 96-98, 101-104, 107-110 (1992)

85. Sehgal V.N., Jain S.: Acne and acneiform dermatoses. J. Indian. Med. Assoc. 89: 80-81 (1991)

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
Chemical Abstracts

Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor

Articles published in this Journal are Indexed or Abstracted in:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ – ANNUAL SUBSCRIPTION
Γλώσσα Πλήρους Κειμένου –
Full Text Language
Ελληνικά – Greek
Παραγγελία – Αγορά –
Order – Buy
Ηλεκτρονική Μορφή: pdf (70 €) –
Digital Type: pdf (70 €)
pharmakonpress[at]pharmakonpress[.]gr
Έντυπη Μορφή (70 € + έξοδα αποστολής)
Printed Type (70 € + shipping)
pharmakonpress[at]pharmakonpress[.]gr

 

Προσθέστε στους σελιδοδείκτες το μόνιμο σύνδεσμο.

Τα σχόλια είναι απενεργοποιημένα.